Galectin Therapeutics Inc (GALT)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -105.917 | -175.055 | -228.556 | -70.221 | -60.466 | -85.956 | -123.187 | -181.085 |
| Return on Equity (%) | -157.772 | -357.857 | -647.879 | -82.284 | -71.153 | -262.792 | 235.423 | 93.46 |
| Return on Invested Capital (%) | -151.588 | -291.591 | -359.129 | -51.541 | -67.439 | -108.24 | -195.22 | -407.253 |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | 0.234 | 0.026 | 0.12 | 0.571 | 0.303 | 0.032 | -0.391 | -0.717 |
| Earnings Per Share | -0.509 | -0.374 | -0.261 | -0.253 | -0.295 | -0.373 | -0.472 | -0.529 |
| Cash Per Share | 0.35 | 0.065 | 0.143 | 0.595 | 0.339 | 0.482 | 0.226 | 0.303 |
| Working Capital Per Share | 0.274 | 0.018 | 0.117 | 0.569 | 0.301 | 0.399 | 0.092 | 0.142 |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | -0.488 | -0.347 | -0.241 | -0.167 | -0.293 | -0.371 | -0.471 | -0.485 |
| EBITDA Per Share | -0.488 | -0.347 | -0.241 | -0.167 | -0.293 | -0.371 | -0.471 | -0.485 |
| Free Cash Flow Per Share | -0.509 | -0.374 | -0.261 | -0.253 | -0.296 | -0.374 | -0.472 | -0.529 |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 32.91M | 35.79M | 41.19M | 56.9M | 57.08M | 59.34M | 59.43M | N/A |
| Year End December 30 2023 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Shares Outstanding | N/A | 59.43M | N/A | 59.58M | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 122.39M |
| Price to Earnings Ratio | -2.73 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 4.77 |
| Price to Book Ratio | -2.03 |
| Dividend Yield | - |
| Shares Outstanding | 62.76M |
| Average Volume (1 week) | 977.25k |
| Average Volume (1 Month) | 431.77k |
| 52 Week Change | 8.94% |
| 52 Week High | 4.2684 |
| 52 Week Low | 1.555 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
